Ahn, D. H., Krishna, K., Blazer, M., Reardon, J., Wei, L., Wu, C., . . . Bekaii-Saab, T. (2016). A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: A retrospective analysis. Ther Adv Med Oncol.
शिकागो स्टाइल उद्धरणAhn, Daniel H., et al. "A Modified Regimen of Biweekly Gemcitabine and Nab-paclitaxel in Patients With Metastatic Pancreatic Cancer Is Both Tolerable and Effective: A Retrospective Analysis." Ther Adv Med Oncol 2016.
एमएलए उद्धरणAhn, Daniel H., et al. "A Modified Regimen of Biweekly Gemcitabine and Nab-paclitaxel in Patients With Metastatic Pancreatic Cancer Is Both Tolerable and Effective: A Retrospective Analysis." Ther Adv Med Oncol 2016.